diabetestalk.net

Humalog Prices

Soaring Insulin Prices Prompt Insurance Shift

Soaring Insulin Prices Prompt Insurance Shift

Since 2002, the cost of insulin has increased by almost 200 percent, according to a new study.Video provided by Newsy Newslook Corrections and clarifications:This story has been updated to reflect fact that Basaglar can’t be used in an insulin pump. Many parents of diabetic children and adults suffering with type 1 or type 2 diabetes are bracing for changes in insurance coverage of their insulin next year, as prices of the vital medication continue to soar. Higher insurance deductibles and changes in the prescription brands covered by some insurers are raising concerns among some people with diabetes. CVS Caremark, a pharmacy benefit manager (PBM), will no longer cover the insulin brand Lantus in favor of a new biosimilar version, Basaglar. Biosimilars are considered the generic versions of "biologic" drugs that are based on natural sources. The company also announced a program last week to further keep diabetes costs down, following a similar move in August by competitor Express Scripts. Diabetes is an epidemic in the United States, affecting nearly 10% of the population or about 29 million people, according to the Centers for Disease Control and Prevention. Of those, more than 8 million people are undiagnosed. Type 1 diabetes — often still called juvenile diabetes — can occur when people are children or adults. Type 2 diabetes is becoming more common with the increase in obesity and sedentary behavior. Prices for Humalog and many insulin brands have increased from about $300 to $500 between January 2013 to October 2016, according to drug discount search company GoodRx. Lantus increased about 60% — from $240 to $380 — in the same time period, GoodRx says. (Photo: T1D Exchange) "It’s definitely unfortunate prices are going up so much and impacting the people Continue reading >>

Humalog Solution For Injection Drug Information, Side Effects, Faqs

Humalog Solution For Injection Drug Information, Side Effects, Faqs

They need to know if you have any of these conditions: -an unusual or allergic reaction to insulin, metacresol, other medicines, foods, dyes, or preservatives This medicine is for injection under the skin or infusion into a vein. This medicine may be given by health care professional in a hospital or clinic setting. It is important to follow the directions given to you by your health care professional or doctor. You should inject this medicine within 15 minutes before or after your meal. Have food ready before injection. Do not delay eating. You will be taught how to use this medicine and how to adjust doses for activities and illness. Do not use more insulin than prescribed. Do not use more or less often than prescribed. Always check the appearance of your insulin before using it. This medicine should be clear and colorless like water. Do not use it if it is cloudy, thickened, colored, or has solid particles in it. It is important that you put your used needles and syringes in a special sharps container. Do not put them in a trash can. If you do not have a sharps container, call your pharmacist or healthcare provider to get one. Talk to your pediatrician regarding the use of this medicine in children. Special care may be needed. It is important not to miss a dose. Your health care professional or doctor should discuss a plan for missed doses with you. If you do miss a dose, follow their plan. Do not take double doses. Visit your health care professional or doctor for regular checks on your progress. A test called the HbA1C (A1C) will be monitored. This is a simple blood test. It measures your blood sugar control over the last 2 to 3 months. You will receive this test every 3 to 6 months. Learn how to check your blood sugar. Learn the symptoms of low and high blood sug Continue reading >>

How To Get Insulin At A Cheaper Price

How To Get Insulin At A Cheaper Price

Insulin can be expensive. If you’re one of the 6 million Americans with diabetes relying on this main-stay treatment, you could be paying out-of-pocket costs anywhere from $120 to $400 per month, according to a 2015 New England Journal of Medicine commentary. Drugs such as Lantus (insulin glargine) and Levemir (insulin detemir) have seen significant cost increases, according to a recent trend report by pharmacy benefit manager Express Scripts. One reason for the high prices is the lack of generic options for insulin. So for now, you’re stuck having to search around to find affordable options. Where do you shop for more affordable insulin? For some people though, high drug costs can mean making difficult financial choices. Our national polls show people might cut back on groceries and paying bills to pay for their medications. To minimize your costs, consider these options: Prescription Assistance Programs If you don’t have health insurance or are without drug coverage, look into applying for a patient assistance program (PAP). Through the nonprofit NeedyMeds, you can find some programs that offer free or low-cost insulin as long as you meet the eligibility requirements. Those are usually based on your insurance status, income, and diagnosis. You might also qualify for a diagnosis-specific program that can help you save on syringes, pumps, and other diabetes supplies. Pharmacists are also a great resource and can help you find a PAP that meets your financial needs. Switch Drugs Another way to save is by asking your doctor whether there’s a lower-priced insulin that’s right for you. While “long-acting” is a more popular type of insulin, it's also more expensive, but that doesn’t necessarily mean it works better. “It’s mostly a marketing ploy,” says M Continue reading >>

Why Treating Diabetes Keeps Getting More Expensive

Why Treating Diabetes Keeps Getting More Expensive

Laura Marston is one of the 1.25 million Americans who suffer from Type 1 diabetes, an autoimmune disorder in which a person's pancreas can't make insulin. She hoards vials of the life-saving medicine in her refrigerator to protect herself from the drug's rising prices. (Jorge Ribas/The Washington Post) At first, the researchers who discovered insulin agonized about whether to patent the drug at all. It was 1921, and the team of biochemists and physicians based in Toronto was troubled by the idea of profiting from a medicine that had such widespread human value, one that could transform diabetes from a death sentence into a manageable disease. Ultimately, they decided to file for a patent — and promptly sold it to the University of Toronto for $3, or $1 for each person listed. It was the best way, they believed, to ensure that no company would have a monopoly and patients would have affordable access to a safe, effective drug. “Above all, these were discoverers who were trying to do a great humanitarian thing,” said historian Michael Bliss, “and they hoped their discovery was a kind of gift to humanity.” But the drug also has become a gift to the pharmaceutical industry. A version of insulin that carried a list price of $17 a vial in 1997 is priced at $138 today. Another that launched two decades ago with a sticker price of $21 a vial has been increased to $255. [This 90-year-old fight over insulin royalties reveals just how much has changed in medicine] Seventy-five years after the original insulin patent expired — a point at which drug prices usually decline — three companies have made incremental improvements to insulin that generate new patents and profits, creating a family of modern insulins worth billions of dollars. The history of insulin captures Continue reading >>

Humalog (insulin Lispro) Is A Fast-acting Insulin That Controls Blood Sugar Around Meal Times.

Humalog (insulin Lispro) Is A Fast-acting Insulin That Controls Blood Sugar Around Meal Times.

Humalog (insulin lispro) is the most effective medication for lowering your blood sugar. Humalog (insulin lispro) can be used even if you have liver or kidney problems, unlike other anti-diabetic medications. Humalog (insulin lispro) is likely to cause moderate weight gain (around 4 to 6 pounds). There is a higher risk for episodes of low blood sugar compared to other anti-diabetic medications. Effects do not last long enough to control your blood sugar for a whole day. Humalog (insulin lispro) is a synthetic version of the insulin hormone. It acts like the insulin your body produces to process sugars and fats, and keep your blood sugar stable after meals. Sign up and get Pill Talk, the latest in health & medicine news from Iodine What to expect when you take Humalog (insulin lispro) for Type 2 diabetes Source: FDA product label and Iodine pharmacists Manufacturers don’t say how common these side effects are when taking Humalog for diabetes Who is this drug for? This medication treats type 1 diabetes in adults. Continue reading >>

Insulin Prices Have Skyrocketed, Putting Drug Makers On The Defensive

Insulin Prices Have Skyrocketed, Putting Drug Makers On The Defensive

Here’s a sticking point for diabetics: the cost of insulin more than tripled — from $231 to $736 a year per patient — between 2002 and 2013, according to a new analysis. The increase reflected rising prices for a milliliter of insulin, which climbed 197 percent from $4.34 per to $12.92 during the same period. Meanwhile, the amount of money spent by each patient on other diabetes medications fell 16 percent, to $502 from $600, according to a research letter published Tuesday in the Journal of the American Medical Association. “Insulin is a life-saving medication,” said Dr. William Herman, a coauthor of the analysis and a professor of medicine and epidemiology at the University of Michigan School of Public Health. “There are people with type 1 diabetes who will die without insulin. And while there have been incremental benefits in insulin products, prices have been rising. So there are people who can’t afford them. It’s a real problem.” The analysis also found that the cost of various widely used oral diabetes drugs either dropped in price or did not rise nearly as significantly as insulin. Metformin, for instance, which is available as a generic, fell to 31 cents in 2013 from $1.24 per tablet in 2002. And the newer class of diabetes drugs known as DPP-4 inhibitors rose 34 percent since becoming available in 2006. The researchers analyzed data from nearly 28,000 diabetes patients found in the Medical Expenditure Panel, a database on health care costs maintained by the US Department of Health and Human Services. About 1 in 4 people used insulin and two-thirds took a pill. Toward the end of the study period, a small percentage began taking new injectable medicines that are designed to complement pills. There have been previous efforts to track insulin pric Continue reading >>

Insulin Price Hikes Tell Us A Lot About What's Wrong With Drug Pricing In America

Insulin Price Hikes Tell Us A Lot About What's Wrong With Drug Pricing In America

Ballyscanlon/Getty Images When inventor Frederick Banting discovered insulin in 1923, he refused to put his name on the patent. He felt it was unethical for a doctor to profit off a discovery that would save lives. Banting’s co-inventors, James Collip and Charles Best, sold the insulin patent to the University of Toronto for a mere $1. They also wanted everyone who needed their medication to be able to afford it. Today Banting and colleagues would be spinning in their graves: Their drug, which many of America’s 30 million diabetics rely on, has become the latest poster child for pharmaceutical price gouging. On May 2, the pharmaceutical giant Eli Lilly raised the prices of its insulin medications, Humalog and Humulin, by 7.8 percent, according to newly obtained records from CNBC’s Meg Tirrell. And Lilly is not acting alone: Sanofi and Novo Nordisk, the only two other companies that manufacture insulin in the US, have been jacking up insulin prices recently too. Patients can now expect to pay upward of $400 per month for the century-old drug. Drug companies use the “cost of innovation” argument to justify the price increases — but critics don’t buy their reasoning, and diabetics who depend on the daily lifesaving medication are livid. In January, patients filed a class action lawsuit accusing the three companies of price fixing. The American Diabetes Association's board of directors has also asked Congress to investigate insulin price increases. While the US represents only 15 percent of the global insulin market, it generates almost half of the pharmaceutical industry’s insulin revenue. According to a recent study in JAMA Internal Medicine, in the 1990s Medicaid paid between $2.36 and $4.43 per unit of insulin; by 2014, those prices more than tripled, de Continue reading >>

Buy Humalog (insulin Lispro) Vials 10 Ml 100iu/ml Online

Buy Humalog (insulin Lispro) Vials 10 Ml 100iu/ml Online

Humalog (Insulin Lispro) Vials 10 mL 100 IU/mL QTY TYPE PRICE PRICE PER UNIT 1 10ML 100IU/ML VIAL $71.63 $71.63 2 10ML 100IU/ML VIAL $111.80 $55.90 3 10ML 100IU/ML VIAL $151.98 $50.66 4 10ML 100IU/ML VIAL $192.16 $48.04 5 10ML 100IU/ML VIAL $237.35 $47.47 6 10ML 100IU/ML VIAL $279.12 $46.52 7 10ML 100IU/ML VIAL $321.44 $45.92 8 10ML 100IU/ML VIAL $362.88 $45.36 9 10ML 100IU/ML VIAL $403.38 $44.82 10 10ML 100IU/ML VIAL $444.20 $44.42 VIEW ALL INSULIN PRODUCTSPLACE A NEW INSULIN ORDER What is Humalog Insulin Lispro? Humalog is the brand name of a variety of insulin analog products that includes insulin lispro, which is a rapid-acting insulin analog solution. Rapid-acting insulin analogs are also referred to as bolus, or mealtime insulin. It is genetically engineered from a safe laboratory strain of E. coli. bacteria specifically to help control the spike in blood sugar level during and after eating. Vials contain insulin lispro for subcutaneous (under the skin) injection. It is available as Humalog (insulin lispro) in a 10 mL 100 IU/mL vial. What is it used for? Humalog insulin lispro injection is used for the treatment of adults and children living with type 1 diabetes or type 2 diabetes. It has also shown effectiveness in helping prevent diabetic nephropathy, diabetic neuropathy, and cardiovascular disease, although it has not been officially approved for the prevention of any of these conditions. It is indicated for the treatment of those people who need insulin for maintenance of blood sugar levels and also for the initial stabilization of diabetes mellitus. It is short-acting, and it is meant for use together with a longer acting insulin, such as Humulin N (insulin isophane NPH), except when used in a subcutaneous (under the skin) insulin infusion pump. How does it w Continue reading >>

Humalog Kwikpen Price

Humalog Kwikpen Price

Humalog Kwikpen is a portable insulin device given to people who have type 2 diabetes. Containing insulin lispro, Humalog Kwikpen is manufactured by Eli Lilly and Company Limited. Other active ingredients of this medicine are glycerol, zinc oxide, m-cresol, hydrochloric acid and sodium hydroxide. Humalog Kwikpen is prescribed specifically to provide insulin for people with diabetes. Insulin is a hormone that helps the body in properly using the sugar found in the blood. It particularly helps prevent blood sugar from increasing to dangerous levels. People with diabetes don’t produce enough insulin in their bodies, and this is why insulin devices like Humalog Kwikpen are prescribed to them. The amount of insulin given to a patient will depend on the diagnosis of a physician, who may need regular measurement of the patient’s blood sugar levels. At times, the amount of Humalog may be changed depending on factors like changes to the diet, changes to the patient’s health, changes in physical activity, or use of another insulin type. Humalog Kwikpen Cost Information Humalog Kwikpen prices vary depending on the store that retails it. A carton of Humalog that contains five kwikpens can go for as low a $280 to as much as $350. However, buyers may get it at a lower price from online stores if they use discount coupons. Continue reading >>

Lilly Insulin Prices Under Microscope

Lilly Insulin Prices Under Microscope

INDIANAPOLIS — Over the past 20 years, while the price of a gallon of milk climbed 23 percent and the sticker on a Dodge Caravan minivan rose 21 percent, the list price of the insulin Humalog, made by Eli Lilly and Co., shot up 1,157 percent. Other Lilly insulins saw hefty price increases, too, including Humulin, on the market since 1982. It has seen price increases totaling nearly 800 percent over the last two decades. The soaring prices at Indianapolis-based Lilly — and two other insulin makers, whose prices are climbing at similar rates — are sending sticker shock through the diabetes community. In recent months, patients have filed lawsuits and called for congressional investigations, and now they’re planning a demonstration next month in front of Lilly’s headquarters on South Delaware Street. The actions are casting a bright glare on Lilly’s oldest and perhaps most famous franchise. The company was the first to mass produce insulin in the 1920s, a move that allowed it to attract scientists and make other breakthroughs in fields from cancer to depression. Click here to purchase photos from this gallery It’s a critical time for Lilly, as it tries to increase its dominance in the $10 billion diabetes-drug market against chief rivals Sanofi of France and Novo Nordisk of Denmark. Lilly CEO David Ricks continues to point to diabetes as a key area for investment and growth, but the company’s ability to keep patients and physicians satisfied could depend on how well it addresses their concerns over prices. Already, some physicians say high insulin prices across the industry are causing financially strapped patients to ration or discontinue their medicines, which could lead to serious medical problems. “It’s an everyday thing,” said Dr. Michael Hancock Continue reading >>

Humalog U-100 Insulin

Humalog U-100 Insulin

Overview How to use Side effects Precautions Storage Drug interactions Overdose More Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Read the Patient Information Leaflet provided by your pharmacist before you start using this medication and each time you get a refill. If you have any questions, ask your doctor, diabetes educator, or pharmacist. Learn all preparation and usage instructions from your health care professional and the product package. Before using, check this product visually for particles or discoloration. If either is present, do not use the insulin. Insulin lispro should be clear and colorless. Before injecting each dose, clean the injection site with rubbing alcohol. Change the injection site each time to lessen injury under the skin and to avoid developing problems under the skin (lipodystrophy). Insulin lispro may be injected in the stomach area, the thigh, the buttocks, or the back of the upper arm. Do not inject into skin that is red, swollen, or itchy. Do not inject col Continue reading >>

The Prices For Life-saving Diabetes Medications Have Increased Again

The Prices For Life-saving Diabetes Medications Have Increased Again

A Type 1 diabetes patient holds up bottles of insulin. Reuters/Lucy Nicholson Insulin prices have been rising — increases that mean some people are spending as much on monthly diabetes-related expenses as their mortgage payment. It's led some people living with diabetes to turn to the black market, crowdfunding pages, and Facebook pages to get access to the life-saving drug. At the same time, the companies that make insulin have faced pressure from politicians including Senator Bernie Sanders, class-action lawsuits that accuse the companies of price-fixing, and proposed legislation in Nevada. Even in the face of this criticism, two of those drugmakers — Eli Lilly and Novo Nordisk — raised the list price of their insulins again in 2017. Diabetes is a group of conditions in which the body can't properly regulate blood sugar that affects roughly 30 million people in the US. For many people living with diabetes — including the 1.25 million people in the US who have type-1 diabetes — injecting insulin is part of the daily routine. Insulin, a hormone that healthy bodies produce, has been used to treat diabetes for almost a century, though it's gone through some modifications. As of May 2, the list price of Humalog, a short-acting insulin, is $274.70 for a 10 ml bottle, an increase of 7.8% from what the list price had been since July 2016. On May 2, Lilly also took a 7.8% list price increase to Humulin, an older form of insulin. Novo Nordisk, which also makes a short-acting insulin, increased its prices to the drug in 2017. In February, the drugmaker raised its price to $275.58 for a 10 ml bottle, up 7.9% from what the list price had been since July 2016. In December, Novo Nordisk committed to limiting all future drug list price increases from the company to single d Continue reading >>

Eli Lilly Raised Prices On 9 Drugs Last Week

Eli Lilly Raised Prices On 9 Drugs Last Week

Indianapolis drug giant Eli Lilly raised list prices of nine of its medicines last week between 6 and 10 percent, according to data obtained by CNBC. The increases, taken on May 2, were for drugs including the blood thinner Effient (9.9 percent), the psoriasis drug Taltz (6.9 percent) and the insulins Humalog and Humulin (7.8 percent). The increases fit a pattern at Lilly and many other drugmakers of single-digit percentage hikes once or twice a year, despite political pressure and intense scrutiny of the practices. Lilly has come under fire for the price of its insulin drugs in particular, leading Senator Bernie Sanders to call for a federal investigation into collusion. Lilly and other insulin makers have denied any such activity. Lilly confirmed the price increases in an emailed statement to CNBC, and noted the list prices "do not reflect the significant discounts and rebates that we provide to ensure patients have adequate access to our medicines." "The net price increase that Lilly recognizes is significantly less," spokesman Mark Taylor wrote. "In fact, in 2016, the average discount to list price on our U.S. portfolio rose to 50 percent and net prices rose just 2.4 percent in the U.S." Rebates on list prices of medicines are negotiated by pharmacy benefits managers. Drugmakers argue few patients are exposed to the list prices of medicines because of these discounts and rebates. One of the largest pharmacy benefits managers, Express Scripts, announced this week a program to offer lower drug prices to patients without health insurance or who have high-deductible plans that make out-of-pocket costs for medicines untenable. Lilly's chief executive, Dave Ricks, appeared on CBS This Morning with Express Scripts Chief Tim Wentworth to praise the program, called Inside Rx Continue reading >>

Why Walmart Insulins Aren’t The Answer To High Insulin Prices

Why Walmart Insulins Aren’t The Answer To High Insulin Prices

A diabetes advocate contrasts the performance of generic insulins versus the more popular brands. Commentary Some people don’t understand why people with diabetes get upset at the price of insulin. They see insulin for sale at a relatively reasonable price in Walmart and don’t see the problem. What they don’t know is that these Walmart insulins just don’t perform nearly as well as the more expensive insulins, and that gap in performance can have a very negative effect on the health of people with diabetes. There are three insulins available at Walmart for the price of $25 – NPH, Regular, and 70/30 (a mix of the two). NPH was first approved by the FDA in 1950, Regular was approved in 1982, 70/30 in 1989. That means NPH has been around for 66 years, Regular for 33 years, 70/30 for 27 years. Take a moment and think about what healthcare was like in 1950. Now, I’m sure someone is saying, “Well, they must still work if they are still being sold.” And they do, but they don’t work in the same way. These insulins are not interchangeable. If a person with Type 1 diabetes were to switch from a Humalog/Lantus insulin regimen to Regular and NPH, it would drastically alter their lifestyle, making blood sugar control more irregular and raising A1C scores. The biggest issue is that whereas Lantus is steady, NPH peaks. A person using NPH must keep a very set dietary schedule, making sure to eat meals and snacks at certain times to correspond with peak times of an insulin dose. The strict schedule is difficult for everyone, but especially for children. They are unable to alter their daily schedules and must always be sure to eat at specific times. Even if they’re not hungry, they must eat to avoid low blood sugar. And if they are hungry, they often cannot have more t Continue reading >>

Lilly Announces Program To Provide Insulin At Discounted Prices

Lilly Announces Program To Provide Insulin At Discounted Prices

Changes in insurance benefit design have increased the cost of insulin for some people. While discounts and rebates paid by manufacturers make insulin affordable for most people, they don't directly help the uninsured or people in the deductible phase of their high-deductible plans. And while some high-deductible plans exempt insulin from the deductible phase, others require people to pay most or all of the retail price until the deductible is met - meaning these people don't fully benefit from rebates when they visit the pharmacy. By using the Blink Health platforms, people who pay full price for most Lilly insulins may save 40 percent. This discount program will be the first time branded medicines will be discounted via the Blink Health platform, which has previously only been used for generic prescription drugs. "We understand the burden people face when paying full price for insulin," said Mike Mason, vice president, Lilly Diabetes. "This platform will effectively allow Lilly to lower our insulin retail prices for users of this platform while not affecting the reimbursement system for other people living with diabetes." Lilly has met with multiple leaders in the diabetes community, including leading advocacy groups and people with diabetes, about the price of insulin for several months. Lilly and Express Scripts started working on options for people who pay full retail price earlier this fall. Enrique Conterno, president of Lilly Diabetes, said today's announcement will hopefully drive additional change within the health care system for people who use insulin. "The health care system is incredibly complex, and we hope this program is a first step that will drive more thinking and innovative solutions for people with diabetes," Conterno said. "A more extensive soluti Continue reading >>

More in insulin